Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Rotschafer

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Burn Care & Rehabilitation|March 1, 1997
Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuriesL L Hoey, S J Tschida, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogensG H Ross, L B Hovde, K H Ibrahim, et al.
JAMA|September 10, 1982
Gentamicin dosing errors with four commonly used nomogramsT S Lesar, J C Rotschafer, L M Strand, et al.
Therapeutic Drug Monitoring|November 1, 1991
Individualizing amikacin regimens: accurate method to achieve therapeutic concentrationsD E Zaske, R J Cipolle, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelM W Garrison, K Vance-Bryan, T A Larson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting techniqueK Vance-Bryan, D R Guay, S S Gilliland, et al.
Therapeutic Drug Monitoring|August 1, 1994
Comparison of gentamicin pharmacokinetic parameters determined by fluorescence polarization immunoassay and latex agglutination methodsK J Madaras-Kelly, S Mihalovic, D Zittel, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1982
Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendationsJ C Rotschafer, K Crossley, D E Zaske, et al.
Pharmacotherapy|April 17, 1998
Current management of human bitesW F Bunzli, D H Wright, A T Hoang, et al.
Drug Intelligence & Clinical Pharmacy|June 11, 1978
Pharm.D. for all: who will provide the necessary resources?R J Cipolle, J C Cloyd, H G McCoy, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Burn Care & Rehabilitation|March 1, 1997
Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuriesL L Hoey, S J Tschida, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogensG H Ross, L B Hovde, K H Ibrahim, et al.
JAMA|September 10, 1982
Gentamicin dosing errors with four commonly used nomogramsT S Lesar, J C Rotschafer, L M Strand, et al.
Therapeutic Drug Monitoring|November 1, 1991
Individualizing amikacin regimens: accurate method to achieve therapeutic concentrationsD E Zaske, R J Cipolle, J C Rotschafer, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1990
Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic modelM W Garrison, K Vance-Bryan, T A Larson, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1993
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting techniqueK Vance-Bryan, D R Guay, S S Gilliland, et al.
Therapeutic Drug Monitoring|August 1, 1994
Comparison of gentamicin pharmacokinetic parameters determined by fluorescence polarization immunoassay and latex agglutination methodsK J Madaras-Kelly, S Mihalovic, D Zittel, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1982
Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendationsJ C Rotschafer, K Crossley, D E Zaske, et al.
Pharmacotherapy|April 17, 1998
Current management of human bitesW F Bunzli, D H Wright, A T Hoang, et al.
Drug Intelligence & Clinical Pharmacy|June 11, 1978
Pharm.D. for all: who will provide the necessary resources?R J Cipolle, J C Cloyd, H G McCoy, et al.
Pageof 9